Abstract |
This single-dose, double-blind, randomized, placebo-controlled study evaluated the analgesic efficacy of both 25 and 50 mg of flurbiprofen ( Ansaid, Upjohn) compared with 650 mg of aspirin and placebo in 164 patients who had undergone dental impaction surgery. Using the highly sensitive dental pain model, flurbiprofen appears to be an effective, peripherally acting analgesic with a rapid onset of activity. In the current study, it was superior to aspirin in terms of peak effect and duration of action. Although flurbiprofen is much more potent than ibuprofen, its side-effect profile did not differ markedly from that of ibuprofen in this single-dose study.
|
Authors | S A Cooper, G Mardirossian |
Journal | The American journal of medicine
(Am J Med)
Vol. 80
Issue 3A
Pg. 36-40
(Mar 24 1986)
ISSN: 0002-9343 [Print] United States |
PMID | 3515922
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Placebos
- Propionates
- Flurbiprofen
- Aspirin
|
Topics |
- Adult
- Aspirin
(adverse effects, therapeutic use)
- Clinical Trials as Topic
- Double-Blind Method
- Drug Evaluation
- Female
- Flurbiprofen
(adverse effects, therapeutic use)
- Humans
- Male
- Pain, Postoperative
(drug therapy)
- Placebos
- Propionates
(therapeutic use)
- Tooth Extraction
|